Page header image

Aspirin Exacerbated Respiratory Disease (AERD): References

Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Updated 2021. Accessed June 2021.

Stevens W, Buchheit K, Cahill KN. Aspirin-exacerbated diseases: advances in asthma with nasal polyposis, urticaria, angioedema, and anaphylaxis. Curr Allergy Asthma Rep. 2015 Dec;15(12):69. doi: 10.1007/s11882-FLABA015-0569-2.

Pongdee T. Aspirin-exacerbated respiratory disease (AERD). American Academy of Allergy, Asthma, and Immunology. https://www.aaaai.org/Legacy/conditions-and-treatments/library/asthma-library/aspirin-exacerbated-respiratory-disease. Accessed June 2021.

Bottrell J. Asthma subgroups: aspirin sensitive respiratory disease (AERD). Asthma.net. https://asthma.net/living/subgroups-aspirin-sensitive-respiratory-disease-aerd/. December 13, 2016. Accessed June 2021.

Stevens WW, Peters, AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease (AERD). Journal of Allergy and Clinical Immunology: In Practice, 2017-07-01, Volume 5, Issue 4, Pages 1061-1070.e3.

White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018 Sep 13;379(11):1060-1070. doi: 10.1056/NEJMra1712125.

© 2022 Change Healthcare LLC and/or one of its subsidiaries
Page footer image